baber/WOPTO huggingface dataset:
Patent CA-2356412-A1 (CA)
Title: Screening method
Inventor: SHIMOMURA YUKIO
IPC: A61P3/10
Filed: 1999-12-27
Abstract: A method for screening a compound or its salt capable of altering the bonding properties of MCH or its salt to SLC-1 or its salt, characterized by using MCH  or its derivative or its salt and SLC-1 or its salt, etc. The above screening method is useful in screening an SLC-1 agonist which is usable as appetite (eating) stimulating agents and preventives and remedies for weak pains, atonic bleeding, before and after expulsion, uterine recovery insufficiency, caesarean section, artificial interruption of pregnancy, milk congestion, etc.  and an SLC-1 antagonist which is usable as antiobestic agents (drugs), appetite (eating) regulators, and preventives and remedies for excessively strong pains, tonic uterine contraction, fetal asphyxia, rupture of uterus, cervical rupture, premature birth, Prader-Willi syndrome, etc.
Patent CA-2357265-A1 (CA)
Title: Improved additive for livestock feeds
Inventor: SOLA JOSE
IPC: A23K1/00
Filed: 2001-09-07
Abstract: Improved particulate feed additives and methods are provided for enhancing feed utilization efficiency in a ruminant animal by adding to the feed of the animals a particulate feed additive comprising a particulate carrier substrate coated with a sufficient amount of a nonionic surfactant to enhance the utilization of the feed by the animal and a sufficient amount of an antioxidant agent to substantially enhance the shelf life of the feed additive. The methods and compositions result in enhanced weight gain and/or milk production by the animal.
Patent CA-2358729-A1 (CA)
Title: Computer aided method of circuit extraction
Inventor: BEGG STEPHEN
IPC: G06F17/50
Filed: 2001-10-12
Abstract: A method and apparatus for extracting circuit design information from a pre-- existing semiconductor integrated circuit (IC) or at least a portion thereof is described. It includes imaging at least a portion of two or more physical layers of the pre--existing IC to obtain stored electronic images of the physical IC layers, converting the stored electronic images of the physical IC layers to a vector format, horizontally and vertically aligning the vector format data of the electronic images of the physical IC layers, and providing a multi-layer display of the aligned vector data. A net- list or schematic is generated from the multi-layer display of the vector data. The netlist and/or schematic may be generated as a number of individual pages by providing a template of circuit elements and placing a circuit element over a portion of the display corresponding to the circuit element. The template of circuit elements may include transistors, logic gates or complex circuit blocks. The vector data may be altered to correct errors in the images or manipulated to correct the alignment of the images. In addition, the schematic may be traced to the image of the physical IC layer.
Patent CA-2361058-A1 (CA)
Title: Netting system for use with bleachers and grandstands
Inventor: DENNY DAVID S
IPC: E04H3/12
Filed: 2001-11-02
Abstract: The present invention is a netting system (10) for use with bleachers and grandstands (11) to prevent children, persons, and debris from falling to the ground. A  first end (12a) of a net (12) is operatively connected to a cable (18) proximate an attachment point (11a) proximate the top of the bleachers (11). Then, a second end (12b) of the net (12) is passed over the understructure (11c) of the bleachers (11) and then operatively connected to a cable (25) proximate an attachment point (11b) proximate the bottom of the bleachers (11).
Patent CA-2363712-A1 (CA)
Title: Long lasting insulinotropic peptides
Inventor: L ARCHEVEQUE BENOIT
IPC: C07K14/16
Filed: 2000-05-17
Abstract: Modified insulinotropic peptides are disclosed. The modified insulinotropic peptides are capable of forming a peptidase stabilized insulinotropic peptide.  The modified insulinotropic peptides are capable of forming covalent bonds with one or more blood components to form a conjugate. The conjugates may be formed in vivo or ex vivo. The modified peptides are administered to treat humans with diabetes and other related diseases.
Patent CA-2367762-A1 (CA)
Inventor: ZANELLATO ALBERTO
IPC: C08F10/00
Filed: 2000-03-20
Abstract: La présente invention a pour objet un catalyseur bimétallique destiné à la (co)polymérisation d'.alpha.-oléfines, comprenant un co-catalyseur constitué d'un hydrure ou d'un composé organométallique d'un élément des groupes 1, 2 ou 13 du tableau périodique et un composant solide constitué d'au moins 95 % en poids de titane, de magnésium, de hafnium, d'aluminium, de chlore et de groupes carboxylates R-COO, dans lesquels R représente un hydrocarbure aliphatique, cycloaliphatique ou aromatique contenant de 1 à 30 atomes de carbone. Au moins 80 % du titane est dans un état d'oxydation +3 et au moins 1 % dudit titane dans un état d'oxydation +3 présente une configuration géométrique de coordination tétraédrique. Ledit catalyseur permet de produire des polymères oléfiniques, notamment du polyéthylène, ayant un poids moléculaire élevé, au moyen de procédés de polymérisation en solution à des températures supérieures à 200 degré .C.
Patent CA-2371191-A1 (CA)
Title: Plug-in coupling
Inventor: FRIEDRICH PETER
IPC: F16L37/138
Filed: 2000-05-31
Abstract: The invention relates to a plug-in coupling, comprising a base body (6), a sealing ring (12, 13), a locking ring (40) and an annular body which can be connected to the base body (6). A pipe end (4, 5) can be locked in position, using the locking ring (40). The invention aims to improve the plug-in coupling, so that a connection can be made with at least one pipe end in a simple, functionally safe manner, whereby pipes consisting of different materials can be used. According to the invention, the pipe end (4, 5) can be inserted into an axial annular gap (27) between the base body (6) and the annular body (18, 19) in such a way that the sealing ring (12) lies adjacent to the interior of the pipe end (4, 5), making a good seal with the same and that in addition, the locking ring (40) is located in the annular gap (27). Said locking ring is prestressed and adjoins the locking surface (20) of the annular body (18) on one side and the exterior surface of the inserted pipe end (4, 5) on the other side. In addition, a locking ring (40) is situated in the annular gap (27) which is prestressed and adjoins the locking surface (20, 21) of the annular body (18, 19) on one side and the exterior surface of the inserted pipe end (4, 5) on the other.
Patent CA-2373141-A1 (CA)
Inventor: MIKKELSEN ODD-HARRY
IPC: F25C5/00
Filed: 2000-04-11
Abstract: In an ice storage (10, 12, 14, 16) the aim is to ensure that ice is chipped off that surface of the ice mass in the storage, which stems from the water which froze to ice first. Likewise, efficient discharging of chipped-off ice to external conveyor devices (23) is ensured. This is achieved by means of a particular ice storage floor construction (16) consisting of parallel, elongate, tubular elements (18) placed with intermediate slots. The floor elements (18) carry carriers (20) in the form of strip-like ice-chipping elements, and the tubular floor elements (18) are supported individually rotational and are preferably driven collectively. The ice-chipping elements may alternatively be formed through the cornered cross-sectional shape of the floor elements, which provide distinct, longitudinal edge portions of good chipping and carrying properties.
Patent CA-2376702-A1 (CA)
Title: A teatcup liner, a teatcup and a milking member
Inventor: KASSIBRAHIM JAN
IPC: A01J5/08
Filed: 2000-06-09
Abstract: The invention refers to a teatcup liner, a teatcup and a milking member. The teatcup liner (1) is mountable in a teatcup shell (2), having a first end (3) and a second end (4), in such a manner that it in the mounted state extends through the teatcup shell (2) and forms an inner space (5) to a teat and an outer space (6) between the teatcup shell and the teatcup liner. The teatcup liner (1) includes an opening for introducing a teat into the inner space. The opening is located at the first end. The teatcup liner also includes a grip area (10), which is arranged to be gripped by a grip portion (11) of the teatcup shell in such a way that the grip area is surrounded by and abuts the grip portion. The grip area (10) has, seen in a cross section, a non-circular shape. The teatcup liner (1) has a connection portion (20) for being connected to a teatcup claw (9). The connection portion includes means (22) arranged to define a rotary position for the teatcup liner (1) in relation to the teatcup claw (9).
Patent CA-2377503-A1 (CA)
Title: Diode recovery current suppression circuits
Inventor: MANTOV GUEORGUI I
IPC: H02M1/34
Filed: 2000-06-13
Abstract: Diode recovery current suppression circuits are disclosed for use with power  supplies. A power supply circuit including the diode recovery current suppression circuit may include a main inductor and a main diode coupled to the end of the main inductor. In such a context, the diode recovery current suppression circuit can include (a) a set of additional inductive windings, (b) an auxiliary inductor, and (c) an auxiliary diode. The set of additional  inductive windings are coupled to the end of the main inductor such that the  diode recovery current suppression circuit is coupled in parallel with the main diode.
Patent CA-2381739-A1 (CA)
Inventor: LIMOGES JOSEPH SERGE
IPC: G06F13/14
Filed: 2002-04-15
Abstract: An adaptive spin latch system is provided for use in a multiprocessor computer system. The spin latch system includes a run queue, a spin latch module and a wait queue.  The run queue is adapted to store agent index data correlated to at least one agent in run mode. The spin latch module is adapted to put the at least one agent into sleep mode for a period of time correlated to a number of agents awaiting access to a resource. The wait queue is adapted to store agent index data correlated to the at least one agent in sleep mode. A method of regulating access by agents to a resource in a multiprocessor computing system is also provided.
Patent CA-2384726-A1 (CA)
Title: Formulations for parenteral use of estramustine phosphate and amino acids
Inventor: COLOMBO PAOLO
IPC: A61K45/06
Filed: 2000-09-13
Abstract: A pharmaceutical formulations which comprises a parenterally acceptable carrier or diluent and estramustine phosphate and a basic amino acid. The formulation can be administered according to a combined chemotherapy regimen  in association with one or more chemotherapeutic agents. The formulation als o enables the estramustine phosphate to be administered with no side effects a t the site of injection.
Patent CA-2385181-A1 (CA)
Title: Disposable injection device
Inventor: BRUNEL MARC
IPC: A61M5/31
Filed: 2000-09-15
Abstract: The invention concerns a disposable injection device comprising a pre-filled syringe (1) provided with a front nozzle (1a) bearing an injection needle (2) protected with a protective cap (3), and a syringe body (7) housing said syringe. The invention is characterised in that said injection device comprises a hub (32), called hooked hub, comprising at least two radially extensible lugs, designed to be mounted on the protective cap (3) and provided with at least an inner grip for gripping the cap. Moreover, the syringe body (7) comprises a cleavable front section (8b), delimited by a frangible zone (14) and comprising a neck (50) adapted to clamp the lugs of the hooked hub (32), so that the latter tightly grip the protective cap (3), said cleavable section (8b) and hooked hub (32) being provided with joint locking means relatively mobile in translation and in rotation with the latter.
Patent CA-2386036-A1 (CA)
Title: Antiobesity agent
Inventor: TAKADA SHIGEO
IPC: A61K31/765
Filed: 2000-09-28
Abstract: Drugs, drinks and foods which have effects of regulating excessive appetite and promoting the basal metabolism and, therefore, are useful in amelioratin g and/or preventing obesity and potentiating the effects of exercise therapy. Namely, drugs, drinks and foods for regulating appetite, promoting the basal  metabolism, ameliorating and/or preventing obesity and potentiating the effects of exercise therapy which contain as the active ingredient a mixture  of cyclic and/or chain polylactic acids having a degree of condensation of 3  to 19.
Patent CA-2387610-A1 (CA)
Inventor: BECHE NOEL
IPC: B65B7/16
Filed: 2000-10-13
Abstract: The invention relates to packaging for various products. The inventive device for sealing various types of containers comprises a base (2) which is provided with a housing (3) for receiving at least one container (4) and a frame (7) which is provided with at least one means for fixing a seal or similar (30) on said container and which can move between a rest position (A) and a working position above the housing. The invention is characterized in that it comprises means (15) for joining the frame (7) to the base, enabling the frame (7) to be displaced between a working position and an offset position on the side of the housing (3), corresponding to the rest position (A), and wherein the fixing means is aligned in a substantially analogous position to the working position thereof with respect to the vertical. The invention can be used in a machine which is used to heat-seal trays.
Patent CA-2388025-A1 (CA)
Title: Therapy with 2-5a and interferon
Inventor: SILVERMAN ROBERT H
IPC: A61K9/127
Filed: 2000-09-29
Abstract: New methods of treating malignancies in a subject are provided. Such methods  comprise administering 2', 5' oligoadenylate (2-5A) or a biostable analog of  2- 5A to the subject. In some embodiments, IFN is also administered to the subject. Examples of cancers which may be treated according to the present method include, but are not limited to, hairy cell leukemia, Kaposi's sarcom a, CML, B-cell and T-cell lymphomas, melanomas, myelomas, renal cell carcinoma,  ovarian, breast, bronchogenic, bladder, and gastrointestinal carcinomas and acute leukemias, malignant glioma and fibrosarcoma. Methods of treating vira l diseases in a subject are also provided. Such methods comprise administering  interferon and 2', 5' oligoadenylate (2-5A) or a biostable analog of to a subject. Examples of viral diseases which may be treated according to this method include, but are not limited to, hepatitis C, hepatitis B, and viral infections caused by human papilloma virus or a picornavirus. A method of selectively inducing programmed cell death (apoptosis) in cancer cells eithe r in vitro or in vivo is also provided. The method comprises administering 2-5 A or a biostable analog thereof to the cancer cells.
Patent CA-2388591-A1 (CA)
Inventor: LAITINEN-VELLONEN SAKARI
IPC: G01N27/416
Filed: 2000-10-06
Abstract: La présente invention concerne une méthode, destinée à analyser un procédé de fabrication papier, dans laquelle on mesure plusieurs quantités électrochimiques à partir d'au moins un flux de liquide, et on détermine des empreintes caractérisant un bon déroulement de procédé. Les mesures électrochimiques sont mises en oeuvre indépendamment les unes des autres au moyen de séries d'électrodes, chacune comprenant au moins trois électrodes. On utilise, en outre, au moins une mesure de l'odeur émise par le flux de liquide dans l'espace gazeux situé au dessus de la surface libre de liquide.
Patent CA-2390616-A1 (CA)
Title: Fuel cell
Inventor: YAGAMI YUICHI
IPC: H01M8/04
Filed: 2002-06-13
Abstract: A fuel cell includes a separator including a first member made from metal and a second member made from synthetic resin. The separator has a power generating portion corresponding portion including a gas passage portion and opposing portions located on opposite sides of the power generating portion corresponding portion. A manifold portion is formed in the opposing portions. The manifold portion is offset from the gas passage portion. A gas passage connecting portion is formed in the second member and fluidly connects the manifold portion and the gas passage portion. A gas flow adjusting portion is formed for directing a direction of a gas flow at the gas passage connecting portion to a direction perpendicular to a direction connecting the opposing portions and making a gas flow into and from the gas passage portion uniform in the direction perpendicular to a direction connecting the opposing portions.
Patent CA-2390896-A1 (CA)
Inventor: LIN WEN-TSAN
IPC: B62B1/04
Filed: 2002-06-18
Abstract: A locking mechanism is installed in the upper main frame and lower main frame of a folding golf cart and adapted for locking the upper main frame in an extended operative position in axial alignment with the lower main frame. The locking mechanism includes a receptacle fixedly provided in a front end of the lower main frame, and a spring-supported latch means provided at the upper main frame and adapted for engaging into the receptacle to lock the upper main frame when the upper main frame turned to the extended operative position.
Patent CA-2399588-A1 (CA)
Inventor: BRIAND JEAN-PIERRE
IPC: H01L21/04
Filed: 2001-02-07
Abstract: The invention concerns a method for treating a surface and a corresponding diamond surface (5A). The method consists in producing ions each having at least three positive charges and in emitting a beam of said ions towards a diamond surface, so as to make at least one surface zone conductive under the effect of the ions. Advantageously, conductive islands (6) are thus formed having a diameter less than 150 nm, which are then preferably used as reservoir for an electron (having a diameter less than 10 nm) or as reservoirs for re-powering cold cathodes. The invention is applicable to microelectronics and for making cold cathodes.
Patent CA-2400411-A1 (CA)
Inventor: WITHERS JAMES C
IPC: C01B31/02
Filed: 2001-02-16
Abstract: The present invention is directed to a nanotube coated with diamond or diamond-like carbon, a field emitter cathode comprising same, and a field emitter comprising the cathode. It is also directed to a method of preventing the evaporation of carbon from a field emitter comprising a cathode comprised of nanotubes by coating the nanotube with diamond or diamond-like carbon. In another aspect, the present invention is directed to a method of preventing the evaporation of carbon from an electron field emitter comprising a cathode comprised of nanotubes, which method comprises coating the nanotubes with diamond or diamond-like carbon.
Patent CA-2402157-A1 (CA)
Inventor: SLAUGHTER DAVID C
IPC: C12Q1/34
Filed: 2001-03-02
Abstract: L'invention concerne des procédés de détection de contaminants chitineux sur des matériaux biologiques non chitineux. Ces procédés sont précis, très reproductibles, rapides et relativement économiques. Ils sont bien adaptés à des applications commerciales, en particulier dans les industries agricole et alimentaire où les matériaux biologiques (par exemple, les produits alimentaires) sont régulièrement testés pour des contaminants (par exemple, insecte, moisissure, champignon, etc.). Dans une réalisation, les procédés consistent à mettre en contact un échantillon biologique avec une sonde constituée d'une lectine qui se lie à la chitine, à mettre en contact l'échantillon avec une pectinase, et à détecter la liaison de la lectine avec la chitine, la liaison étant indicative d'une présence de chitine dans l'échantillon biologique.
Patent CA-2402557-A1 (CA)
Inventor: PETERSEN HANS
IPC: C07D307/87
Filed: 2001-03-09
Abstract: The invention relates to a method for the preparation of citalopram comprising, in either order, subjecting a compound of formula (III) wherein Y is a cyano group or a group which may be converted to a cyano group, R is hydrogen, -O-R1, NH2, NHCH3 or -N(CH3)2 wherein R1 is selected from hydrogen , alkyl, alkenyl, alkynyl and optionally alkyl substituted aryl or aralkyl; to  i) reduction of the double bond in the side chain of formula -CH=CH-COR: ii)  conversion of the group -COR or a reduced form thereof to a dimethylaminomethyl group; and iii) if Y is not cyano, conversion of the gro up Y to a cyano group; followed by isolation of citalopram base or a pharmaceutically acceptable acid addition salt thereof.
Patent CA-2403451-A1 (CA)
Inventor: ROSENBAUM WALTER
IPC: G06Q30/00
Filed: 2001-03-16
Abstract: An electronically transmitted purchasing order is registered with an online service provider (2). The service provider then electronically sends an order to the corresponding producers or suppliers (3), comprising data characterising the purchasing order, and an electronic instruction for printing corresponding labels with the address of the recipient as well as documents such as an invoice, a delivery note, a letter and information in the layout used by the online service provider, as required, is sent to one or more printing centres (4) with the digital data required for this and the data for characterising the purchasing order. The printed documents (4.1) are shipped to the producers/suppliers in one or more envelopes which are provided with the characteristic data, and here the items and the printed documents are brought together according to said characteristic data and once ready for shipping in the online service provider layout, sent to the customer/orderer (1).
Patent CA-2406073-A1 (CA)
Inventor: SACKTOR TODD C
IPC: A61P25/28
Filed: 2001-04-20
Abstract: The present invention provides methods and compositions for enhancing memory in animals, including humans by the administration of an effective amount of an atypical form of protein kinase C such as protein kinase M zeta (PKM.zeta.) or protein kinase C iota/lambda.
Patent CA-2406855-A1 (CA)
Title: Novel insulin/igf/relaxin family polypeptides and dnas thereof
Inventor: OGI KAZUHIRO
IPC: C12N5/06
Filed: 2001-04-20
Abstract: (1) A polypeptide having an amino acid sequence being identical or substantially identical with the amino acid sequence represented by SEQ ID  NO:7 (strand A); (2) a polypeptide having an amino acid sequence being identical or substantially identical with the amino acid sequence represented by SEQ ID NO:8 (strand B); (3) a polypeptide wherein the strand A and B are bonded to each other via a disulfide bond (double-stranded) or its salt; (4) DNAs encoding the same, etc. These polypeptides and DNAs encoding the same are usable in, for example, diagnosing, treating and preventing diseases (diabetics, etc.) caused by metabolic errors of energy sources such as carbohydrates (for example, sugar metabolism, lipid metabolism).
Patent CA-2409076-A1 (CA)
Title: Composition and method for growing, protecting, and healing tissues and cells
Inventor: PETITO GEORGE D
IPC: A61L15/22
Filed: 2002-10-21
Abstract: A composition and method for facilitating the growth, protection and healing of tissues and cells in animals and humans.      Formulated as a either a powder, gel, paste, film, fluid injectable, rehydratable freeze-dried paste or sponge, sprayable solution, topically applied patch with adhesive and reservoir system, an intermediate for coatables such as films and bandages, a matrix for membranes, or as a matrix of flexible polymer(s), or delivered as either an orally ingestible liquid, tablet or capsule. The main ingredients are hydrolyzed Type I collagen having a molecular weight of 1,000-10,000, polysulfated glycosaminoglycans, a hyaluronic acid salt, a glucosamine salt, and optionally, a chelated manganese ascorbate and L-malic acid.      In the topical form, the composition is administered to the cleaned wound site where it absorbs exudate, provides a physical barrier to bacterial infestation, reduces pain, and expedites wound healing by having chemotactic, hemostatic, bacteriostatic, and other therapeutic benefits. Scars are advantageously reduced.